Publication date: Aug 11, 2026
Melanoma treatment for patients with clinical adenopathy has improved outcomes with neoadjuvant immunotherapy (NAI). Some sentinel lymph node (SLN)-positive patients have larger pathologic metastases that might be identified on ultrasound (US) preoperatively. We sought to identify SLN-eligible patients with larger nodal metastases and identify characteristics to estimate patients who might have nodal metastases identified by staging US. Patients with clinical stage IB/II melanoma who underwent a SLNB for which the pathological size of the metastases were retrospectively identified. Comparative statistics were performed for patients with macrometastases (≥ 10 mm) compared with micrometastases (
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Melanoma |
| pathway | KEGG | Melanoma |
| disease | MESH | adenopathy |
| disease | MESH | metastases |
| disease | MESH | micrometastases |
Original Article
(Visited 5 times, 1 visits today)